Clear Harbor Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$265K 436
2024
Q4
$265K Buy
+10,000
New +$271K 0.02% 324
2024
Q3
Sell
-11,500
Closed -$322K 392
2024
Q2
$322K Buy
+11,500
New +$317K 0.03% 282
2024
Q1
Sell
-5,000
Closed -$144K 394
2023
Q4
$144K Buy
+5,000
New +$151K 0.01% 340

Other funds holding PFE

Clear Harbor Asset Management's PFE Position: Q2 2026 in Review

Clear Harbor Asset Management reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $43.1K and leaving 144,614 shares worth $3.48M. The position accounts for 0.21% of the portfolio, ranked #94.

Clear Harbor Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.92M in Q1 2015. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Clear Harbor Asset Management held 144,614 shares of Pfizer worth $3.48M as of Q2 2026.
  • Clear Harbor Asset Management sold 1,649 Pfizer shares in Q2 2026, an estimated $43.1K.
  • Pfizer made up 0.21% of Clear Harbor Asset Management's portfolio in Q2 2026, its #94 holding.
  • Clear Harbor Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Clear Harbor Asset Management's Pfizer position peaked at $4.92M in Q1 2015.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.